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Bylategestation,thematuringhypothalamo-pituitary-adrenal(HPA)axisaidsthefetusinrespondingtostress.Hypoxiarepresents
a signiﬁcant threat to the fetus accompanying situations such as preeclampsia, smoking, high altitude, and preterm labor. We
developed a model of high-altitude (3,820m), long-term hypoxia (LTH) in pregnant sheep. We describe the impact of LTH on the
fetal HPA axis at the level of the hypothalamic paraventricular nucleus (PVN), anterior pituitary corticotrope, and adrenal cortex.
At the PVN and anterior pituitary, the responses to LTH are consistent with hypoxia being a potent activator of the HPA axis
and potentially maladaptive, while the adrenocortical response to LTH appears to be primarily adaptive. We discuss mechanisms
involved in the delicate balance between these seemingly opposing responses that preserve the normal ontogenic rise in fetal
plasma cortisol essential for organ maturation and in this species, birth. Further, we examine the response to, and ramiﬁcations
of, an acute secondary stressor in the LTH fetus. We provide an integrative model on the potential role of adipose in modulating
these responses to LTH. Integration of these adaptive responses to LTH plays a key role in promoting normal fetal growth and
development under conditions of a chronic stress.
1.Introduction
Hypoxia represents a major threat to the developing fetus
and often accompanies situations of preeclampsia, preterm
labor, smoking, and high altitude. The impact that hypoxia
has on the fetus depends on a variety of factors such as
stage of gestation, severity of the hypoxic episode, duration
of hypoxia, and the association with other confounders such
as acidemia and hypercapnia. Severe hypoxic events can lead
to fetal death or exert major deleterious impacts on develop-
ment and function on fetal organs, including major damage
of the CNS. However, fetuses are often and perhaps routinely
exposed to less severe hypoxic episodes. While these hypoxic
conditions may impact fetal growth, eﬀects on other organ
systems are less clear.
Due to its long gestational length, similarity of endocrine
and physiological systems, and relative ease of fetal and
maternal instrumentation, the sheep has emerged as a ma-
jor animal model for studying the impact of hypoxia on
the developing fetus. These studies have largely focused
on so-called acute hypoxia in which a moderate-to-severe
hypoxia (a decrease in fetal PO2 of 50% or greater) is
induced for times ranging from minutes to several hours
or chronic hypoxia in which the fetus is made hypoxic for
one to several days. Experimentally, acute fetal hypoxia can
be induced by maternal hypoxia [1–3], restricting blood
ﬂow to the uterus and placenta on the maternal side [4],
or reducing umbilical blood ﬂow by cord compression [5–
7]. More prolonged fetal hypoxemia can also be initiated
by repeated umbilical cord compression [7–9], as well as
placental embolization [10, 11] and restriction of uterine
blood ﬂow [12]. These methods induce either a rather pure
hypoxic episode or hypoxia accompanied with acidemia or
hypoglycemia. Longer duration hypoxic situations (months)
have been created in sheep by maternal carunclectomy,
reducing the placentation area of the uterus [13]. However,
the hypoxia in this model is secondary to nutrient restric-
tion.2 Journal of Pregnancy
Our model of long-term hypoxia (LTH) uses pregnant
ewes maintained at high altitude (3,820m, Barcroft Labora-
tory White Mountain Research Station, Bishop, CA) from
approximately 40 days’ gestational age onward resulting
in a maintained fetal PO2 of ∼18mmHg (normal ∼23–
25mmHg) thus resulting in a moderate state of continuous
hypoxia [14–16]. Under these conditions, fetal hypoxia is
achievedwithoutaccompanyingacidosis,thepregnanciesare
of normal duration, and the fetuses do not exhibit growth
restriction [15, 17]. Considering that hypoxia is a potent
fetal stressor even at the moderate level attained in our
model of LTH, the ability of the LTH fetus to mount an
adaptive response circumventing preterm birth and growth
restriction is remarkable. The focus of our studies has been
the adaptive responses of the fetal hypothalamo-pituitary
adrenocortical(HPA)andadrenomedullaryaxis.Duringour
studies on these components of the stress response, we have
also initiated studies into how LTH impacts development of
the fetal perirenal adipose tissue and interactions between
this tissue and the HPA axis.
2 .Ef f ec t so fL T Ho nt h eF et alHP AA xis
Since hypoxia is a potent activator of the fetal HPA axis, we
initially explored the eﬀect of LTH on the systemic endocrine
HPA response by quantifying basal immunoreactive (IR)
ACTH and cortisol concentrations in fetal plasma as well
as the response of LTH fetal sheep to an acute secondary
stressor (severe hypoxia via hypotension or umbilical cord
occlusion: UCO) during the later stages of gestation [14, 16,
18]. Surprisingly, despite the continued stress of LTH, fetal
plasma cortisol concentrations were not elevated in these
fetuses compared to normoxic control fetuses at 136–141
days gestation (term is ∼145 days). Thus, the LTH fetus
maintains a seemingly normal late gestation maturation of
the fetal adrenal cortex and thus preserves the late gestation
exponential rise in cortisol that precipitates organ matu-
ration and, in this species, birth. Similar to cortisol, fetal
plasma concentrations of IR-ACTH were also similar in the
LTH fetus compared to normoxic controls. Thus, by initial
observations,thesefetusesapparentlyadapttoLTHsuchthat
this chronic hypoxic perturbation is no longer perceived by
the fetus as stressful.
Paradoxically, the HPA axis response to an acute sec-
ondary stressor such as hypotension or UCO [14, 16]i s
decidedly diﬀerent than predicted based on the basal circu-
lating levels of IR-ACTH and cortisol. Indeed, we found in
responsetotheseacutestressorsthatfetalplasmacortisolwas
elevated in the LTH fetuses compared to normoxic controls
while concentrations of fetal plasma IR-ACTH achieved
were similar in LTH and normoxic fetuses. These ﬁndings
implicatedapotentialintra-adrenalmechanism(s)thatallow
the adrenal cortex of the LTH fetus to respond to an acute
stress with increased cortisol production while maintaining
the normal basal ontogenic maturation.
Neural input has been shown to play a physiological
role in regulating cortisol production. For instance, bilateral
section of the splanchnic nerve reduces cortisol production
in response to endogenous or exogenous ACTH [19, 20]
while stimulation of the splanchnic nerves enhances cortisol
output [21, 22]. In near term normoxic fetal sheep, it has
been reported that sinoaortic denervation [23]o rs p l a n c h -
nic nerve section [24] decreased the cortisol response to
acute stress without aﬀecting stress-induced ACTH release.
However, in the LTH fetus, the enhanced cortisol response
to a secondary stressor does not appear to be mediated by
neural input to the adrenal cortex since adrenal denervated
LTH fetuses responded in a manner similar to the intact
LTH fetuses [25]. Thus, the increased response of the adrenal
cortex to an acute secondary stress in the LTH fetus does
not emanate from a neurally mediated mechanism. Based on
these initial observations, we further explored the origin(s)
of the observed adaptive responses of the HPA axis to LTH at
the level of the hypothalamus and anterior pituitary as well
as the adrenal cortex.
3. Effect of LTH on the Hypothalamusand
Anterior Pituitary
Increases in the bioactivity of plasma IR-ACTH have been
noted in late gestation fetal sheep, both in terms of ontogeny
and in response to an acute stressor [26–29]. In adults, the
majority of circulating IR-ACTH consists of fully processed
ACTH1−39. However in the ovine fetus, a considerable
proportionofIR-ACTHistheunprocessedACTHprecursor,
proopiomelanocortin (POMC), or the so-called 22kDa
proACTH,whichisthepartiallyprocessedN-terminalregion
of POMC through the carboxyl terminus of ACTH [30, 31].
In addition, a few other POMC-derived products containing
the ACTH peptide, likely produced via incomplete and/or
improper processing at the anterior pituitary or lung [32,
33], are also found in the fetal circulation. Both POMC
and 22kDa proACTH have been noted to inhibit ACTH-
stimulated cortisol production or exhibit week ACTH bioac-
tivity [34]. These precursors exhibit varying degrees of cross-
reactivity in classical one-site ACTH radioimmunoassays or
ELISAs thus giving rise to the concept of bioactivity of
IR-ACTH. Therefore, during late gestation the processing
of POMC to ACTH in the anterior pituitary corticotrope
matures and this maturation is largely governed by the
hypothalamic paraventricular nucleus. This was conﬁrmed
by our observation that stereotaxic lesion of the fetal PVN,
the source of the two major corticotrophin releasing factors,
CRH and AVP, prevents the late gestation increase in POMC
processing to ACTH [35]. Thus, we hypothesized that LTH,
acting as a chronic stressor, may have enhanced POMC
processing to ACTH in the fetal anterior pituitary.
To evaluate this possibility, we analyzed both basal and
stress-induced ACTH1−39and ACTH precursor concentra-
tions in fetal plasma of LTH compared to control fetuses
using a two-site IRMA speciﬁc for ACTH1−39 a n da nA C T H
precursor IRMA [36]. In response to an acute secondary
stressor, UCO, fetal plasma concentrations of ACTH1−39
were higher in the plasma of LTH fetuses compared to sim-
ilarly stressed normoxic fetuses. Although ACTH precursors
were also elevated, it was to a lesser extent than ACTHJournal of Pregnancy 3
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Figure 1: Eﬀects of development under conditions of long-term
hypoxia (LTH) on hypothalamic PVN and anterior pituitary cor-
ticotrope function in the late gestation ovine fetus. LTH upregulates
expression of both CRH and AVP in the parvocellular division
of the PVN. At the level of the anterior pituitary corticotrope,
this increased hypothalamic drive results in increased processing
of POMC to ACTH as well as ACTH release from the gland into
the circulation. The changes at the level of the PVN and anterior
pituitary result in increased basal circulating ACTH as well as an
enhanced ACTH release in response to a subsequent acute stressor.
and thus the ratio of ACTH1−39 to precursors was increased
in the LTH compared to normoxic fetuses, indicating that
the bioactivity of fetal plasma IR-ACTH achieved in the
LTH fetuses was greater than that in normoxic fetuses (see
Figure 1,[ 37]). This is consistent with the enhanced cortisol
response observed in LTH fetuses during this secondary
stressor.Intriguingly,basalplasmaACTH1−39 concentrations
werealsoelevatedintheLTHfetalsheep.Despitetheelevated
plasma levels of ACTH1−39, these fetuses maintain normal
basal cortisol concentrations compared to normoxic control
fetuses.
To support the elevated plasma ACTH1−39,w ef o u n d
enhancedprocessingofPOMCtoACTHintheanteriorpitu-
itary of the LTH fetus, as well as signs of increased secretion
(less stores) accompanied by sustained POMC expression
with a trend toward greater POMC mRNA [36]. Considering
our observations that lesion of the PVN prevents the
enhanced processing of POMC to ACTH during late ges-
tation [35], we hypothesized a hypothalamic origin for the
increased processing of POMC in response to LTH. In our
original report [36], we noted only a trend for hypothalamic
CRH mRNA to be increased in the LTH fetuses using real-
time PCR analysis of whole dissected hypothalami. However,
recently (Ducsay and Myers, unpublished observations)
using in situ hybridization techniques, we found a signiﬁcant
upregulation of both CRH mRNA and AVP mRNA in
the hypothalamic parvocellular division of the PVN. Initial
morphometric analysis also suggests an expansion of the
PVN reﬂecting an increase in the number of CRH neurons
or neurons expressing CRH at detectable levels in response
to LTH.
At the level of the anterior pituitary, we noted increased
mRNA for the CRH1 receptor with decreased CRH1 protein-
the latter perhaps suggestive of a downregulation of this
receptor in response to increased hypothalamic drive to the
anterior pituitary. Of note, anterior pituitary AVP receptor
(V1b) expression (mRNA and protein) was upregulated
in the LTH fetus perhaps indicative of a selective gain of
responsiveness to this ACTH secretagogue [18]. In support
of this potential gain of AVP function in response to LTH,
we also found that ACTH release in response to AVP was
greater in LTH fetal sheep, while the response to CRH
was similar between LTH and normoxic controls. Thus, the
hypothalamicandanteriorpituitarycorticotroperesponseto
LTHappearscomplexandmayrepresentashiftfromCRHto
AVP in the regulation of the HPA axis.
It appears that LTH advances the normal ontogenic
maturation of POMC processing to ACTH at the anterior
pituitary via actions at the level of CRH and more likely,
AVP neurons, in the parvocellular PVN (Figure 1). Upon
casual observation, while this helps to explain the increased
cortisol response to a secondary stressor in the LTH fetus,
it is in conﬂict with the noted maintained normal basal
plasma cortisol levels in these fetuses. Importantly, the
fetal adrenal cortex seems to have developed an adaptive
mechanismpreventinganearlymaturationculminatingwith
a premature rise in fetal plasma cortisol resulting in a growth
restricted, preterm fetus. Thus, we shifted our focus to the
adrenal cortex.
4. Effect of LTH on the OvineFetal
Adrenal Cortex
Based on the elevated basal plasma ACTH1−39 noted in the
LTH fetuses and the capacity for greater cortisol production
in response to a secondary stressor, we initially hypothesized
that the LTH adrenal cortex would have responded corre-
spondingly with an increase in expression of key enzymes
regulating cortisol biosynthesis as well as supporting genes
such as StAR and the ACTH receptor. However, despite
the elevated basal plasma ACTH1−39, expression of two key
enzymesmediatingcortisolsynthesis(CYP11A1andCYP17)
was approximately 50% lower in the LTH adrenal cortex as
was the ACTH receptor [38]. Although we initially did not
observe any change in StAR mRNA, we did note an increase
in the 30kDa spent form of the cholesterol transporter
protein. An increased transport of cholesterol into the inner
mitochondrial membrane, the site of the ﬁrst limiting step
in cortisol biosynthesis via CYP11A1 could help maintain
basal plasma levels of cortisol noted in LTH fetuses despite
the noted lowered expression of the steroidogenic enzymes.
The ﬁndings of decreased, not increased, levels of genes
whose expression is exquisitely dependent upon ACTH in
the LTH adrenal cortex led to a key fundamental question:
namely, what LTH-stimulated mechanism(s) would provide
essentially a brake on early activation and excessive produc-
tion of cortisol, preventing early birth and growth restric-
tion? Initially, we analyzed expression of a key transcription
factor, SF-1, via which ACTH coordinates expression of its
responsive genes in the adrenal cortex. Levels of SF-1 as well
as DAX-1, a transcription factor repressing expression of
CYP17 and CYP11A1, were not altered in the LTH adrenal
cortex [38]. Since these factors also play a key role in adreno-
cortical diﬀerentiation and growth, this is consistent with no
diﬀerences in adrenal zonation or size in the LTH fetus, but4 Journal of Pregnancy
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Figure 2: Eﬀects of development under conditions of long-term
hypoxia (LTH) on adrenocortical function in the late gestation
ovine fetus. LTH increases perirenal adipose expression and
release of leptin as well as adrenocortical leptin receptor (OB-Rb)
expression. LTH also increases zona fasciculate-speciﬁc expression
and activity of eNOS. Combined, leptin and nitric oxide (NO)
s e r v et ol i m i tt h ea b i l i t yo ft h ee l e v a t e df e t a lp l a s m aA C T Ht o
stimulate cortisol production thus allowing for the maintenance of
the normal ontogenic maturation of cortisol production preserving
the prepartum exponential rise of this key steroid. In response to an
acute secondary stress, these mechanisms allow release of cortisol
synthesis thus resulting in an enhanced acute phase production of
cortisol. (ZG-zona glomerulosa, ZF-zona fasciculata, M-medulla).
not with the decreased expression of the downstream target
genes. We also examined expression of factors (pMEIS-1 and
Pbx-1) that act in concert with SF-1 in the bovine adrenal
cortex and thus presumably the highly conserved regulatory
regionsoftheovineCYP11A1andCYP17promoters.Similar
to SF-1, these factors were also expressed to a similar degree
in LTH compared to normoxic adrenal cortices (Ducsay and
Myers [39], unpublished observations). Thus, the eﬀects of
LTH on the transcription of the ACTH-receptor, CYP11A1,
and CYP17 must likely be either through an unknown
repressor or, more likely, via altered activation of these tran-
scription factors. It has been demonstrated that SF-1 activity
is regulated by phosphorylation state, dictated by either
ACTH activated cAMP/PKA pathways or ERK1/2 pathways,
and dependent on protein phosphatase activity [40].
To address the potential for a decreased second messen-
ger response to ACTH, especially in light of the decreased
ACTH receptor expression, we examined cAMP production
in adrenocortical cells obtained from LTH fetuses. Surpris-
ingly, LTH fetal adrenocortical cells generate a similar cAMP
response compared to adrenocortical cells from normoxic
fetuses [41]. In these in vitro studies, we also noted an
additionalperplexingﬁnding:thatcontrarytotheinvivosit-
uation, LTH fetal adrenocortical cells exhibited greater basal
cortisol production, while retaining the noted enhanced
ACTH stimulated cortisol output compared to cells from
normoxic fetuses. A similar enhanced cortisol response to
cAMP was also noted, thus emphasizing that the eﬀect was
potentially downstream from second messenger generation.
Thus,theredonotappeardeﬁcienciesinACTHsignaling
via the major second messenger pathway utilized by the
ACTH receptor. Thus, the noted lower mRNA levels for
the ACTH receptor may not be reﬂected by actual levels
of the ACTH receptor protein or that levels of the ACTH
receptor may not be limiting. Alternatively, lower ACTH
receptor expression may be overcome through more eﬃcient
couplingoftheACTHreceptortoGαsorincreasedadenylate
cyclaseactivity.However,atpresentthesepossibilitiesremain
unexplored. What the in vitro studies did highlight was that
the capacity of these cells to respond to ACTH was decidedly
diﬀerent in vitro compared to the in vivo situation—
namely, in terms of basal versus ACTH stimulated cortisol
production. This implicated additional intra- or extra-
adrenal factors that in vivo act on the fetal adrenocortical
cells limiting the capacity of low resting concentrations
ACTH (5 to 10pM) to stimulate cortisol production under
basal conditions yet allow an enhanced cortisol production
inresponsetoasecondarystressorwithstresslevelsofACTH
(50–100pM). To address these possibilities, we explored
two potential mechanisms that could potentially explain the
noted adaptation of the fetal adrenal cortex to LTH: nitric
oxide (NO) and leptin.
5. Role of Nitric Oxide in Mediating LTH Effects
on Cortisol Biosynthesis
While the lower expression of the ACTH receptor, coupled
with decreased expression of two rate limiting enzymes
mediating cortisol biosynthesis (CYP11A1 and CYP17),
provides a means for the capacity of the LTH fetus to
maintain the normal ontogenic rise in fetal plasma cortisol,
these adaptive changes seem contradictory to the capacity
of the LTH adrenal cortex to produce greater cortisol in
response to a secondary stressor. Although the enhanced
ACTH1−39 released in the LTH fetus in response to a
secondary stressor likely contributes to this boost in cortisol
production, the decreased expression of the ACTH receptor
coupled with lower expression of key enzymes suggests that
other intracellular mechanism are involved in the divergent
capacity for basal cortisol and stress-stimulated cortisol pro-
duction.
We initiated investigations into nitric oxide (NO) as one
potential mediator of the eﬀects of LTH on the adrenal
gland. Nitric oxide has profound inhibitory eﬀects on
steroidogenesisinawiderangeofendocrinetissuesincluding
the adrenal cortex and NO synthases (NOSs) are subject
to regulation by hypoxia (see recent review by Ducsay and
Myers [39]). As such NO represents a potential mechanism
in the adrenocortical adaptation to LTH (Figure 2). Further,
it has been reported that NO concentrations in the plasma
of the LTH fetus are elevated compared to normoxic
fetuses [42]. While the levels in plasma are likely not high
enough to be of physiological importance for regulating
intracellular adrenocortical events, they are indicative thatJournal of Pregnancy 5
NOS expression and/or activity may be elevated in target
organs such as the adrenal gland.
Indeed, we were the ﬁrst laboratory to demonstrate NOS
expression in the fetal adrenal cortex and the eﬀects of NO
on fetal adrenal steroidogenesis. Endothelial NOS (eNOS)
is the predominant NOS isoform in the ovine fetal adrenal
cortex, and more importantly, we demonstrated that LTH
increases eNOS mRNA and protein expression [43] and that
the increased expression was primarily in CYP17 expressing
cellswithinthezonafasciculataindicatingaselectiveincrease
in the cortisol producing adrenocortical layer. In vitro
studies demonstrated that enhancement of NO production
with L-arginine, a NOS substrate, resulted in a signiﬁcant
reduction of ACTH-mediated cortisol production selectively
in LTH-derived fetal adrenocortical cells [44]. The use of
NO donors, DETA-NO, and Sodium Nitroprusside (SNP)
similarly decreased ACTH-mediated cortisol production
while inhibition of NOS activity with L-NAME signiﬁcantly
increased cortisol production in the LTH group but was
withouteﬀectonnormoxicfetus-derivedfetaladrenocortical
cells. In accord with the elevated expression on eNOS, nitric
oxide synthase activity was signiﬁcantly higher in LTH-
derived fetal adrenocortical cells compared to those from
normoxic control fetuses, and this diﬀerence was eliminated
following ACTH treatment. These data indicate that LTH
enhances adrenal cortical sensitivity to the inhibitory eﬀects
of NO on cortisol production. Nitric oxide may, therefore,
play an important role in regulating ACTH-induced cortisol
production in the LTH fetal adrenal [44].
How NO mediates its inhibitory actions on steroidogenic
tissue, including the adrenal, is equivocal. In vascular tissue,
the eﬀects of NO are well established and largely depend
on cGMP pathways (reviewed in [45]). However, the eﬀects
of NO on steroidogenesis in endocrine tissues appear to be
independent of cGMP [46]. One potential mechanism by
which NO inhibits steroidogenesis is via acting on the initial
rate-limiting enzyme, CYP11A1. Nitric oxide competes with
oxygen binding in the active site of CYP11A1 and CYP17
[46, 47]. Further, Peterson et al. [48] suggested that because
these enzymes use several rounds of attack of the heme-
oxygen complex on the steroid substrate, multistep enzymes
(suchasCYP11A1)wouldbemoresensitivetoNOinhibition
than other steroidogenic enzymes. Overall, this competitive
interaction makes NO a potentially eﬀective inhibitor of
steroidogenesis.
Thus, a model can be proposed where eNOS is upreg-
ulated in the LTH fetus, and under basal conditions (low
ACTH), NO decreases the activity of CYP11A1 and per-
haps other cytochrome P450 enzymes helping to limit the
production of cortisol despite the elevated basal ACTH1−39
(Figure 2). During a secondary stress-induced elevation of
ACTH, high levels of ACTH signaling inhibit NOS activity
removing this inhibition resulting in the observed enhanced
cortisol production observed in these fetuses. These ﬁnd-
ings implicate eNOS/NO as an intra-adrenal mechanism.
Importantly the NO eﬀects are also retained in vitro [43,
44]. Therefore, although NO plays a role in providing a
brake on basal cortisol production, it does not appear to
provide a mechanism by which the expression of key genes
is decreased in the LTH adrenal gland. Taken together, these
data implicate additional in vivo factors involved in the
adaptation of the HPA axis to LTH.
6. Role of LeptinMediatingLTHEffects on
Cortisol Biosynthesis
A role for leptin in suppressing the HPA axis in adults has
been established, both at the hypothalamic level as well as
directly at the level of the adrenal cortex. The active or long
form of the leptin receptor (OB-Rb) is found in the adrenal
cortex in rodents, humans [49], and ruminants [50]. Leptin
suppresses cortisol output in response to ACTH stimulation
in adult bovine adrenocortical cells, and this eﬀect was
mediated through an reduction in CYP17 expression [51].
Additional studies conﬁrmed this observation and extended
the inhibitory eﬀect of leptin to expression of CYP11A [52].
In addition to downregulation of steroidogenic enzymes,
leptinalsoappearstoinhibitadrenalglucocorticoidsecretion
by an additional mechanism. Recent studies in the rat
have clearly demonstrated that the leptin inhibition of
corticosterone secretion occurs through a rapid reduction in
expression of both StAR and PBR protein [53, 54].
Although the function(s) of leptin in the adult has been
widely studied, the role of leptin in the fetus is not well
deﬁned. Clearly, leptin is found in the fetal circulation
a n di se x p r e s s e di nf e t a la d i p o c y t e s[ 55, 56] and placental
trophoblast tissue [57]. Intracerebral infusion of leptin
blunted the size of increase that occurred in amplitude and
mean value of plasma ACTH and cortisol pulses near term
[58]. These data are consistent with adult mouse data where
leptin attenuates restraint-induced activation of the HPA
[59]. More recent studies from the McMillen group also
demonstrated an inhibitory eﬀect of leptin on the fetal ovine
HPA.Intravenousleptininfusionssuppressedprepartumrise
in both ACTH and cortisol [60]. Infusion after day 144 did
not aﬀect ACTH but there was still marked suppression of
cortisol up to three days prior to delivery.
Based on this evidence, we initially addressed whether
leptin, a hypoxia inducible gene, was elevated in LTH fetal
sheep. We noted that plasma leptin as well as peri-renal
adipose expression of leptin was signiﬁcantly elevated in
the LTH fetus as was expression of the OB-Rb in both the
adrenal cortex and hypothalamus [61]. While past studies in
the ovine fetus, and largely in adults as well, have focused
on the actions of exogenous leptin in regulating the HPA
axis, we have addressed the role of endogenous leptin in the
HPA adaptation to LTH using a speciﬁc ovine leptin receptor
antagonist. As we have recently communicated [62], a 4-
day infusion of the antagonist to LTH fetuses starting at 139
days of gestation restored expression of both CYP11A1 and
CYP17 to levels similar to those of the normoxic control
fetuses.Surprisingly,theinfusionoftheleptinantagonisthad
no eﬀect on expression of either enzyme in the normoxic
controls and, similarly, did not alter fetal plasma ACTH
or cortisol in these fetuses during the infusion period. In
the LTH fetuses, although CYP11A1 and CYP17 expressions
increased in response to the antagonist, fetal plasma cortisol6 Journal of Pregnancy
levels were not altered and were not diﬀerent from control
fetuses. This indicates that, while leptin may play a role in
mediating the adaptive responses to LTH in CYP expression
in the adrenal gland, clearly other mechanisms exist, such
as NO production, that limit the ability to produce cortisol.
The lack of eﬀect of the antagonist in the control fetuses
would seemingly bring to question the role of leptin in
regulating the HPA axis of the late gestation sheep fetus
in a nonperturbed state. It should be noted that we have
shown that the OB-Rb expression in the ovine fetal adrenal
does decrease signiﬁcantly near term compared to younger
animals at ∼120–130 days’ gestation [63]. Thus, leptin may
play a role in regulating the HPA axis in less mature fetuses
and this regulation is lost near term as the HPA axis rapidly
matures in preparation for birth (Figure 2).
7.HPA Response toLTH:
Adaptive versus Maladaptive
As discussed previously, we have deﬁned changes in function
of the fetal HPA axis in response to development under
conditions of LTH as primarily adaptive, especially at the
level of adrenal cortisol production. Indeed, these responses
appear to support continued normal growth of the fetus in
the face of the stress of sustained, moderate hypoxia. Con-
sidering the essential role of maturation of the fetal HPA axis
and the late gestation exponential rise in fetal plasma cortisol
in initiating parturition in this species, this adaptation also
allows the fetus to remain in utero for the normal length
of gestation. This seems especially critical considering the
lowered oxygen delivery to the fetus, thus allowing the max-
imal opportunity for the fetal growth. As such, the observed
response providing for the normal ontogenic maturation of
adrenocortical function is critically adaptive in nature.
However, the changes we have observed at the level of
the hypothalamic PVN and anterior pituitary corticotrope
may be viewed diﬀerently. Indeed, these changes might be
argued as being maladaptive since they cumulatively result
in enhanced processing of POMC to ACTH1−39 in the cor-
ticotrope and enhanced release of ACTH1−39 into the circu-
lation. Under situations where there is no additional (acute
secondary) stress, the adrenal cortex, perhaps in concert
with adipose derived leptin, has developed mechanisms to
maintain “normal” function. But, when presented with an
acute secondary stress resulting in greater ACTH release,
cortisol production is actually greater than that of age
matched normoxic fetal sheep. Although cortisol production
in response to stress is part of the physiological homeostatic
mechanism(s) helping the organism to survive the stressor,
it could be argued that the excessive production of cortisol
in response to the secondary stress in the LTH fetus is mal-
adaptive. This would be especially true in situations where
theLTH-compromisedfetusissubjectedtorepeatedepisodes
of acute secondary stress or perhaps greatly ampliﬁed when
a longer-term secondary stress occurs. In the ﬁnal weeks of
gestation, this capacity of the LTH fetus to produce a larger
cortisol response to a secondary stress may serve as signal
to terminate the pregnancy in this species indicative of a
dangerously adverse intrauterine environment thus limiting
the potential chance for fetal demise.
Lastly, the changes in gene expression that we have noted
in the perirenal adipose may also provide a means for the
LTH newborn to survive in an adverse environment. Clearly,
theincreasedproductionofleptinprovidesanessentialbrake
to the adrenocortical response to LTH allowing the fetus
to potentially remain in utero for a longer period. Perhaps
moreimportantlyhowever,thechangesingeneexpressionin
the adipose favor the brown fat phenotype that may aid the
newborn LTH fetus in survival in the initial hours after birth.
Similarly, the greater capacity for cortisol production in
responsetoasecondarystressor,ifretainedpost birth,would
seem largely beneﬁcial in a harsh, low oxygen environment.
8. Conclusions
Hypoxia, acute or sustained, is a major threat to the well-
being of a fetus and is a relatively common insult during
human pregnancy. During the ﬁnal third of gestation the
ovine fetal HPA axis undergoes a maturational process in
which the fetus not only develops the capacity to mount a
cortisol response to physiological stressors but also under-
goes an exponential rise in basal cortisol. As with most
mammals, this parturient rise in cortisol is essential for
maturation of fetal organ systems allowing for survival in
the extrauterine environment, after birth [64–66]. However,
sustained or repetitious fetal stressors can activate the
hypothalamic-pituitary-adrenocortical (HPA) axis resulting
in elevated cortisol production and premature maturation
of the adrenal cortex contributing to fetal growth restriction
[67–69]. Nonetheless, the capacity to mount an adrenocor-
tical stress response during late gestation contributes to fetal
survival in the face of the stressor, as happens with adults.
We have established a model of altitude-induced long-term
hypoxia where the ovine fetus develops under continuous
moderate hypoxia. Despite this constant physiological stres-
sor, the fetal HPA axis undergoes a remarkable adaptation
in which the normal ontogenic rise in fetal plasma cortisol
and HPA axis maturation is maintained while preserving
the capacity to mount a stress response. Indeed, the cortisol
response to a secondary stressor is ampliﬁed, undoubtedly to
aid in helping the fetus survive in this hypoxic environment.
We have identiﬁed both adaptive responses at the level of the
hypothalamus and anterior pituitary as well as the adrenal
cortex that contribute to this adaptation to LTH and have
identiﬁed two mechanisms, one intraadrenal (NO produc-
tion) and extra-adrenal (adipose-derived leptin) that play
signiﬁcant roles in maintaining function of the fetal HPA
axis at the level of the adrenal gland. It will be important
to determine if these systems are a unique response to
LTH or are invoked as a general adaptive response to other
intrauterine stressors that aid in fetal survival.
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